Kutok Jeffery 4
4 · Epizyme, Inc. · Filed Mar 21, 2022
Insider Transaction Report
Form 4
Epizyme, Inc.EPZM
Kutok Jeffery
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-03-17+380,000→ 380,000 totalExercise: $1.39Exp: 2032-03-16→ Common Stock (380,000 underlying)
Footnotes (1)
- [F1]This option was granted on March 17, 2022 pursuant to the Company's 2013 Stock Incentive Plan with respect to 380,000 shares of Common Stock, with 25% vesting on March 17, 2023 and the remaining 75% vesting in 36 substantially equal monthly installments thereafter.